netFormulary
 Report : A-Z NHS England items in Formulary 06/07/2020 01:39:45
[Back]
 
Section Status NHS England Name
08.03.04.02 Formulary MHS England Abiraterone Zytiga®
08.02.03 Formulary MHS England Alemtuzumab Lemtrada®
08.01.05 Formulary MHS England Bexarotene Targretin®
08.02 Formulary MHS England Blinatumomab Blincyto®
05.03.03.02 Formulary MHS England Boceprevir Victrelis®
08.01.05 Formulary MHS England Bosutinib Bosulif®
08.01.05 Formulary MHS England Cabazitaxel Jevtana®
08.01.05 Formulary MHS England Carfilzomib Kyprolis®
08.01.05 Formulary MHS England Ceritinib Zykadia
08.01.05 Formulary MHS England Cetuximab Erbitux®
08.01.03 Formulary MHS England Cladribine Mavenclad®
08.01.05 Formulary MHS England Crizotinib Xalkori®
05.03.03.02 Restricted Use MHS England Daclatasvir  Daklinza®
08.01.05 Formulary MHS England Dacomitinib Vizimpro®)
05.03.03.02 Formulary MHS England Dasabuvir Exviera®
08.01.05 Restricted Use MHS England Dasatinib Sprycel®
08.02.04 Formulary MHS England Dimethyl fumarate Tecfidera®
05.03.03.02 Formulary MHS England Elbasvir/Grazoprevir Zepatier®
08.01.05 Formulary MHS England Eribulin Halaven®
08.02.04 Formulary MHS England Glatiramer Acetate Copaxone®
05.03.03.02 Formulary MHS England Glecaprevir and Pibrentasvir Maviret®
08.01 Formulary MHS England Inotuzumab ozogamicin Besponsa®
08.02.04 Formulary MHS England Interferon Beta Avonex®
08.02.04 Formulary MHS England Interferon Beta Rebif®
08.02.04 Formulary MHS England Interferon Beta Betaferon®
08.01.05 Formulary MHS England Ipilimumab Yervoy®
05.03.03.02 Formulary MHS England Ledipasvir and Sofosbuvir Harvoni®
08.01.05 Formulary MHS England Lenvatinib Lenvima® and Kisplyx®
08.02.04 Formulary MHS England Natalizumab Tysabri®
08.02.03 Formulary MHS England Obinutuzumab Gazyvaro ®
08.02.03 Formulary MHS England Ocrelizumab Ocrevus®
05.03.03.02 Formulary MHS England Ombitasvir/ paritaprevir/ ritonavir Viekirax®
08.01.05 Formulary MHS England Paclitaxel - Albumin Bound Formulation Abraxane®
05.03.05 Restricted Use MHS England Palivizumab Synagis®
08.01.05 Formulary MHS England Pertuzumab Perjeta®
05.03.05 Formulary MHS England Ribavirin 
08.01.05 Formulary MHS England Ribociclib 
05.03.03.02 Formulary MHS England Sofosbuvir Sovaldi®
05.03.03.02 Formulary MHS England Sofosbuvir, Velpatasvir and Voxilaprevir Vosevi®
08.01.05 Formulary MHS England Sorafenib Nexavar®
08.01.05 Formulary MHS England Sunitinib Sutent®
05.03.03.02 Formulary MHS England Telaprevir Incivo®
08.02.04 Formulary MHS England Teriflunomide Aubagio®
08.01.05 Formulary MHS England Tivozanib (Fotivda®)
08.01.05 Formulary MHS England Trametinib Mekinist®
08.01.05 Formulary MHS England Trastuzumab Herceptin®
08.01.05 Formulary MHS England Trastuzumab emtansine Kadcyla®
Northern Lincolnshire